Cargando…

The interaction of the ER with ERBB2 and PI3K results in elevated levels of AKT and p90(RSK )in tamoxifen-resistant MCF-7 cells

Detalles Bibliográficos
Autores principales:	Pancholi, S, Lykkesfeldt, A, Johnston, SRD, Dowsett, M, Martin, L-A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233540/ http://dx.doi.org/10.1186/bcr1119

Ejemplares similares

The anti-estrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF7 breast cancer cells refractory to long-term estrogen deprivation through downregulation of ER and IGF signalling
por: Martin, L-A, et al.
Publicado: (2005)

Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer
por: Moon, Hyeong-Gon, et al.
Publicado: (2012)

HOXA5 confers tamoxifen resistance via the PI3K/AKT signaling pathway in ER-positive breast cancer
por: Kim, Clara Yuri, et al.
Publicado: (2021)

Upregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells
por: Hamadneh, Lama, et al.
Publicado: (2020)

Role of p90RSK in Kidney and Other Diseases
por: Lin, Ling, et al.
Publicado: (2019)

Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis
por: Esserman, Laura J, et al.
Publicado: (2005)

Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7.
por: Lykkesfeldt, A. E., et al.
Publicado: (1984)

Radiation therapy induces immunosenescence mediated by p90RSK
por: Imanishi, Masaki, et al.
Publicado: (2022)

ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways
por: Lin, Sheng-Li, et al.
Publicado: (2010)

Differential Response to α-Oxoaldehydes in Tamoxifen Resistant MCF-7 Breast Cancer Cells
por: Nass, Norbert, et al.
Publicado: (2014)

RSK2 and ERα comrades-in-arms in homeostasis and transformation
por: Ludwik, Katarzyna A., et al.
Publicado: (2020)

p90Rsk is not involved in cytostatic factor arrest in mouse oocytes
por: Dumont, Julien, et al.
Publicado: (2005)

Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity
por: Xifró, Xavier, et al.
Publicado: (2011)

Extracellular HSP90α Interacts With ER Stress to Promote Fibroblasts Activation Through PI3K/AKT Pathway in Pulmonary Fibrosis
por: Zhang, Jinming, et al.
Publicado: (2021)

Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells
por: You, Daeun, et al.
Publicado: (2017)

Expression of focal adhesion kinase, Akt/PKB, Elk-1 and p90RSK in rheumatoid arthritis tissues but not at sites of cartilage invasion
por: Seemayer, CA, et al.
Publicado: (2003)

Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells
por: Abdallah, Mohamed E., et al.
Publicado: (2020)

EGFR/HER2 inhibitor AEE788 increases ER-mediated transcription in HER2/ER-positive breast cancer cells but functions synergistically with endocrine therapy
por: Evans, A H, et al.
Publicado: (2010)

The p90 Ribosomal S6 Kinase (RSK) Is a Mediator of Smooth Muscle Contractility
por: Artamonov, Mykhaylo, et al.
Publicado: (2013)

IL-6 Impairs Myogenic Differentiation by Downmodulation of p90RSK/eEF2 and mTOR/p70S6K Axes, without Affecting AKT Activity
por: Pelosi, Michele, et al.
Publicado: (2014)

The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma
por: Isa, Reiko, et al.
Publicado: (2022)

Tamoxifen-Induced Apoptosis of MCF-7 Cells via GPR30/PI3K/MAPKs Interactions: Verification by ODE Modeling and RNA Sequencing
por: Rouhimoghadam, Milad, et al.
Publicado: (2018)

Mechanisms of Gefitinib-mediated reversal of tamoxifen resistance in MCF-7 breast cancer cells by inducing ERα re-expression
por: Zhang, Xia, et al.
Publicado: (2015)

Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer
por: Alves, Carla L., et al.
Publicado: (2023)

Hypoxia-Induced Invadopodia Formation Involves Activation of NHE-1 by the p90 Ribosomal S6 Kinase (p90RSK)
por: Lucien, Fabrice, et al.
Publicado: (2011)

Luteolin suppresses UVB-induced photoageing by targeting JNK1 and p90(RSK2)
por: Lim, Sung H, et al.
Publicado: (2013)

p90RSK Regulates p53 Pathway by MDM2 Phosphorylation in Thyroid Tumors
por: Maietta, Immacolata, et al.
Publicado: (2022)

ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen
por: M. Sieuwerts, Anieta, et al.
Publicado: (2020)

Sea Cucumber Intestinal Peptide Induces the Apoptosis of MCF-7 Cells by Inhibiting PI3K/AKT Pathway
por: Wei, Wei, et al.
Publicado: (2021)

Celastrol inhibits the proliferation and migration of MCF-7 cells through the leptin-triggered PI3K/AKT pathway
por: Chen, Pingping, et al.
Publicado: (2022)

Translating breast cancer research into clinical practice — new approaches and better outcomes
por: Johnston, SRD
Publicado: (2006)

KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer
por: Wei, Dang, et al.
Publicado: (2021)

Estradiol promotes the progression of ER+ breast cancer through methylation-mediated RSK4 inactivation
por: Li, Qiuyun, et al.
Publicado: (2019)

Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF−7/SC Breast Cancer Cells
por: To, Ngoc Bao, et al.
Publicado: (2022)

P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation
por: Li, Ping, et al.
Publicado: (2012)

Regulation of p90RSK phosphorylation by SARS‐CoV infection in Vero E6 cells
por: Mizutani, Tetsuya, et al.
Publicado: (2006)

Dual PI3K/Akt Inhibitors Bearing Coumarin-Thiazolidine Pharmacophores as Potential Apoptosis Inducers in MCF-7 Cells
por: Abdelnaby, Rana M., et al.
Publicado: (2022)

Coffee decoction enhances tamoxifen proapoptotic activity on MCF-7 cells
por: Funakoshi-Tago, Megumi, et al.
Publicado: (2020)

YSY01A, a Novel Proteasome Inhibitor, Induces Cell Cycle Arrest on G2 Phase in MCF-7 Cells via ERα and PI3K/Akt Pathways
por: Xue, Bingjie, et al.
Publicado: (2015)

SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis
por: Gao, Meiling, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_os74d362i3offed5ok8qne8s0l